Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06088212
Status:
RECRUITING
Last Update Posted:
2023-11-14
First Post:
2023-09-27
Brief Title:
Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor
Sponsor:
Baker Heart and Diabetes Institute
Organization:
Baker Heart and Diabetes Institute
Study Overview
Official Title:
Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor the Cog-HF Trial
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Cog-HF
Brief Summary:
This study will test the feasibility and effectiveness of an innovative model of care for cognitively impaired patients with heart failure This program aims to improve cognition reduce dementia risk and cardiovascular events and will be supported by innovative digital technology for wide scale rollout and implementation Findings from this research will transform the way healthcare is delivered to cognitively impaired patients with heart disease who have a very high risk of developing dementia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None